Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
Completed · Not applicable
Conditions studied: Idiopathic Nephrotic Syndrome, Frequently Relapsing Nephrotic Syndrome
In brief
This study evaluates the impact of transcutaneous auricular Vagus Nerve stimulation (taVNS) therapy on the incidence of nephrotic syndrome relapses in children with idiopathic nephrotic syndrome. Participants will perform taVNS 5 minutes a day for 6 months total, monitoring for signs of nephrotic syndrome relapse with both labwork and clinical symptoms.
Key facts
- Study ID
- NCT04169776
- Run by
- Northwell Health
- People needed
- 7
- Starts
- 2019-12-01
- Expected to finish
- 2021-12-01
- Last updated by the study team
- 2022-09-28
Who can join
Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Northwell — New Hyde Park, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.